ChemicalBook > CAS DataBase List > Mavrilimumab

Mavrilimumab

Product Name
Mavrilimumab
CAS No.
1085337-57-0
Chemical Name
Mavrilimumab
Synonyms
CAM 3001;Mavrilimumab;Mavrilimumab (anti-CD116);Research Grade Mavrilimumab;Research Grade Mavrilimumab(DHD11501)
CBNumber
CB48080815
Formula Weight
0
MOL File
Mol file
More
Less

Mavrilimumab Property

storage temp. 
Store at -20°C
form 
Liquid
color 
Colorless to light yellow
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

Mavrilimumab Chemical Properties,Usage,Production

Uses

Mavrilimumab (CAM-3001) is an investigational human IgG4 monoclonal antibody (MAb) targeting GM-CSF receptor alpha which is currently being developed for the treatment of RA. GM-CSF plays a central role in the pathogenesis of rheumatoid arthritis (RA) through the activation, differentiation, and survival of macrophages and neutrophils.

in vivo

Mavrilimumab (3–100 mg/kg, intravenously, once weekly for at least 11 weeks) inhibits GM-CSF signalling. Prolonged high-dose administration may induce neutrophilic lipid deposition, foam cell formation, cholesterol clefts, and granulomatous inflammation in alveolar macrophages. Mavrilimumab exhibits immunogenicity in crab-eating macaques, with repeated administration inducing anti-drug antibodies that accelerate drug clearance and reduce exposure levels[2].

Animal Model:Cynomolgus monkey models [2]
Dosage:3–100 mg/kg
Administration:intravenous, once weekly for at least 11 weeks
Result:Produced foam cells in the lungs.

Mavrilimumab Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Mavrilimumab Suppliers

Shanghai YuanYe Biotechnology Co., Ltd.
Tel
021-61312847; 18021002903
Fax
QQ:3008007432
Email
3008007409@qq.com
Country
China
ProdList
71826
Advantage
60
ShangHai Biochempartner Co.,Ltd
Tel
177-54423994 17754423994
Fax
QQ:2853530913
Email
2853530910@QQ.com
Country
China
ProdList
8000
Advantage
62
Guangzhou Hongyuan Chemical Co.,Ltd
Tel
15817493340
Email
981810490@qq.com
Country
China
ProdList
1566
Advantage
58
Wuhan Chemstan Biotechnology Co., Ltd.
Tel
027-65317797 15926423062
Fax
QQ:422450190
Email
422450190@qq.com
Country
China
ProdList
10308
Advantage
58
TargetMol Chemicals Inc.
Tel
4008200310
Email
marketing@tsbiochem.com
Country
China
ProdList
24961
Advantage
58
Biolab Reagents
Tel
027-65279366 18108604356
Email
products@biolabreagent.com
Country
China
ProdList
9868
Advantage
58
Wuhan Jingkangen Biomedical Technology Co., Ltd
Tel
13720134139 086-15871494362 13720134139
Email
orders@jknbiochem.com
Country
China
ProdList
6762
Advantage
58
Shanghai Yifei Biotechnology Co. , Ltd.
Tel
021-65675885 18964387627
Email
customer_service@efebio.com
Country
China
ProdList
11973
Advantage
58
Shanghai Aladdin Biochemical Technology Co.,Ltd.
Tel
400-6206333 13167063860
Email
anhua.mao@aladdin-e.com
Country
China
ProdList
48457
Advantage
58
Changsha Fuzhen Biotechnology Co.,LTD
Tel
0731-13823398 15111215862
Email
313359644@qq.com
Country
China
ProdList
4161
Advantage
58
Wanxin Biotechnology (Jiaxing) Co., LTD
Tel
0573-83568680 18057391398
Email
3956524501@qq.com
Country
China
ProdList
1442
Advantage
58
Atagenix Laboratories
Tel
027-87008169 17762441161
Email
info@atagenix.com
Country
China
ProdList
10001
Advantage
58
Sangon Biotech (Shanghai) Co.,Ltd.
Tel
400-821-026
Email
Sales@sangon.com
Country
China
ProdList
6710
Advantage
58
AntibodySystem Laboratories SAS
Tel
33175446423
Email
support@antibodysystem.com
Country
China
ProdList
6739
Advantage
58
Biosynth Biological Technology (Suzhou) Co Ltd
Tel
51288865780
Email
sales@biosynth.com
Country
China
ProdList
6051
Advantage
58
Cell Sciences
Tel
9785721070
Email
info@cellsciences.com
Country
China
ProdList
6308
Advantage
58
Guangzhou Zhuanyan Biotechnology Co., Ltd.
Tel
18926165828
Country
CHINA
ProdList
198
Advantage
58
Proteintech China
Tel
--
Fax
--
Email
Proteintech-CN@ptglab.com
Country
CHINA
ProdList
6290
Advantage
58

1085337-57-0, MavrilimumabRelated Search:


  • Mavrilimumab
  • Research Grade Mavrilimumab(DHD11501)
  • Mavrilimumab (anti-CD116)
  • CAM 3001
  • Research Grade Mavrilimumab
  • 1085337-57-0